Skip to main content

Table 1 Clinical material

From: Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus

 

T1DM without DN

T1DM with DN

 

All

Female

Male

All

Female

Male

N

599

357

242

578

265

313

Age (years)

40 ± 8

40 ± 9

40 ± 8

44 ± 6

44 ± 7

45 ± 6

Duration of diabetes (years)

26 ± 8

26 ± 8

26 ± 8

32 ± 8

32 ± 8

32 ± 8

HbA1c (%)

7.5 ± 1.1

7.5 ± 1.1

7.4 ± 1.1

7.4 ± 1.9

7.4 ± 2.1

7.4 ± 1.7

BMI (kg/m2)

26.0 ± 4.4

25.7 ± 4.7

26.6 ± 3.7

25.7 ± 5.3

25.2 ± 5.7

26.2 ± 4.8

Creatinine (mg/dL)

0.9 ± 0.2

0.8 ± 0.1

1.0 ± 0.1

2.1 ± 1.9

1.9 ± 1.6

2.3 ± 2.0

Cystatin (mg/L)

0.8 ± 0.1

0.8 ± 0.1

0.8 ± 0.1

2.2 ± 1.7

2.2 ± 1.6

2.4 ± 1.7

Cholesterol (mg/dL)

185.0 ± 31.3

188.7 ± 30.9

179.7 ± 31.2

186.3 ± 45.9

190.3 ± 47.3

183.1 ± 44.5

HDL (mg/dL)

59.1 ± 15.9

64.8 ± 15.5

51.0 ± 12.4

53.6 ± 17.3

59.3 ± 18.2

48.9 ± 15.0

Systolic BP (mm Hg)

118 ± 12

116 ± 12

122 ± 12

131 ± 19

130 ± 20

133 ± 18

Diastolic BP (mm Hg)

71 ± 8

70 ± 7

74 ± 8

74 ± 11

72 ± 11

75 ± 11

  1. All data are means ± SD. T1DM = Type 1 diabetic patients, DN = diabetic nephropathy.